RPL11, an R Factor of Pseudomonas aeruginosa Determining Carbenicillin and Gentamicin ResistanceKorfhagen, T. R.; Loper, J. C.
doi: 10.1128/AAC.pmid: 806259
R factor RPL11 from Pseudomonas aeruginosa determines multiple drug resistance including resistance to gentamicin and carbenicillin. The host range and incompatibility properties of RPL11 are those of incompatibility group P-2. Strains harboring the factor are not altered with respect to the major immunotypes 1 through 7 of Parke-Davis, or with respect to pyocin type by using the 18 indicators of Jones and co-workers. Analytical ultracentrifugation of crude extracts of R factor-containing strains shows a band of satellite DNA with a buoyant density of 1.717 g/cm 3 . Antimicrob Agents Chemother. 1975 January; 7(1): 69-73 Copyright © 1975 American Society for Microbiology . All Rights Reserved.
Clinical Pharmacology of SisomicinRodriguez, Victorio; Bodey, Gerald P.; Valdivieso, Manuel; Feld, Ronald
doi: 10.1128/AAC.pmid: 1137357
Studies were conducted in 30 patients with neoplastic diseases. Twelve patients received sisomicin intramuscularly at doses of 20 mg/m 2 and 40 mg/m 2 . The mean peak serum concentration occurred at 1 h and was 2.5 µg/ml and 4.0 µg/ml, respectively. Ten patients received intravenous sisomicin at doses of 30 mg/m 2 during 30-min infusion. Mean peak serum level determined at 30 min was 5.1 µg/ml. The levels gradually decreased and at 6 h was 0.6 µg/ml. The serum half-life was 160 min. Serum levels determined in eight patients who received sisomicin by continuous infusion at doses of 30 mg/m 2 every 6 h were greater than 1.4 µg/ml during the 6-h period. The urinary excretion of sisomicin during the 6-h period after intramuscular administration of 20 mg/m 2 and 40 mg/m 2 was 49 and 61%, respectively. The pharmacology of sisomicin is similar to gentamicin. Antimicrob Agents Chemother. 1975 January; 7(1): 38-41 Copyright © 1975 American Society for Microbiology . All Rights Reserved.
Comparative In Vitro Antifungal Activity of Amphotericin B and Amphotericin B Methyl EsterHowarth, William R.; Tewari, Ram P.; Solotorovsky, Morris
doi: 10.1128/AAC.pmid: 1137359
The in vitro antifungal activity of amphotericin B methyl ester (AME), a water-soluble derivative of amphotericin B, was compared to that of the parent compound against a variety of pathogenic and potentially pathogenic fungi. AME has a significant antifungal activity, but the activity of AME was slightly lower than that of amphotericin B. Among the yeast-like organisms, only the yeast cells of Sporothrix schenckii were more resistant than others to both antibiotics, with a minimal fungicidal concentration of 5 to 10 µg/ml. The yeast cells of other fungi were killed at concentrations of 1 µg or less of either antibiotic per ml. The filamentous forms of S. schenckii and Oidiodendron kalrai were more resistant than the filamentous forms of other dimorphic fungi to both drugs. The minimal fungicidal concentration for S. schenckii was 10 µg/ml and for O. kalrai , 50 µg/ml. The dermatophytes, phycomycetes, and dematacious and other potentially pathogenic fungi were inhibited fairly well by both drugs, but up to 50 µg/ml was required for fungicidal action. The water solubility and wide spectrum of antifungal activity of AME warrant evaluation of its chemotherapeutic activity against experimental fungal infections. Antimicrob Agents Chemother. 1975 January; 7(1): 58-63 Copyright © 1975 American Society for Microbiology . All Rights Reserved.
Identification of Harper-Cawston Factor as Thymidine Phosphorylase and Removal from Media of Substances Interfering with Susceptibility Testing to Sulfonamides and DiaminopyrimidinesFerone, R.; Bushby, S. R. M.; Burchall, J. J.; Moore, W. D.; Smith, D.
doi: 10.1128/AAC.pmid: 1169907
Rich media support the growth of bacteria in the presence of concentrations of sulfonamides and diaminopyrimidines that are highly inhibitory when the organisms are grown on minimal media. Many such rich media can be made more suitable for susceptibility testing by the incorporation of lysed horse blood. Harper and Cawston characterized the active substance, Harper-Cawston factor (HCF), and later studies indicated it to be a protein. It has now been identified as thymidine phosphorylase. The identification follows from the identical purification pattern of HCF and thymidine phosphorylase activities from horse blood to a high degree of purity. Blood of goats, sheep, oxen, geese, chickens, cows, dogs, rats, and humans had neither biological activity. The identification of HCF as thymidine phosphorylase is consistent with the earlier findings of Koch and Burchall (1971) that most of the interfering effects of rich media could be accounted for by their thymidine contents, and that thymidine is much more active in this respect than is thymine. Antimicrob Agents Chemother. 1975 January; 7(1): 91-98 Copyright © 1975 American Society for Microbiology . All Rights Reserved.
Mechanism of Plasmid-Mediated Resistance to Cadmium in Staphylococcus aureusChopra, I.
doi: 10.1128/AAC.pmid: 1137361
The mechanism of plasmid-mediated resistance to cadmium in Staphylococcus aureus was investigated. Protein synthesis in cell-free extracts from resistant or susceptible bacteria was equally susceptible to inhibition by Cd 2+ , but spheroplasts from resistant bacteria retained their resistance. Resistant bacteria did not have a decreased affinity for cations in general, nor was active metabolism required for exclusion of Cd 2+ . The kinetics of Cd 2+ uptake into susceptible and resistant bacteria suggested that the conformation of membrane proteins in resistant bacteria may be important in the exclusion of Cd 2+ . Antimicrob Agents Chemother. 1975 January; 7(1): 8-14 Copyright © 1975 American Society for Microbiology . All Rights Reserved.
Selective Inhibition of Growth by the Proline Analogue Thiazolidine-4-Carboxylic Acid and Its Probable Mode of Action in Saccharomyces cerevisiaePaterniti, James R., Jr.; Wilkie, David; Eaton, Norman R.
doi: 10.1128/AAC.pmid: 1094943
Cells of Saccharomyces cerevisiae showed differential growth inhibition when cultured on various carbon sources in the presence of the proline analogue thiazolidine-4-carboxylic acid (TZ). On 0.5% yeast extract, 2% glucose and TZ (10 mg/ml) medium, growth lags from 8 to 10 h were observed, after which cells recovered and growth proceeded normally. Growth was totally inhibited on a medium of 0.5% yeast extract, 3% ethanol, and 5 mg of TZ per ml. This inhibition was not due to the inability of cells to undergo aerobic respiration, since similar media containing glycerol instead of ethanol allowed growth. Proline added to the culture medium reversed the lag on glucose and TZ medium but did not promote recovery on ethanol and TZ medium. TZ was found to have two probable modes of action in yeast. It was a noncompetitive inhibitor of yeast alcohol dehydrogenase, and it was also found to be incorporated into cellular protein. Uptake studies using 14 C-labeled TZ showed that the recovery on glucose was correlated with the progressive exclusion of the analogue from cells. Antimicrob Agents Chemother. 1975 January; 7(1): 25-31 Copyright © 1975 American Society for Microbiology . All Rights Reserved.
Effect of Lincomycin and Clindamycin on Peptide Chain InitiationReusser, Fritz
doi: 10.1128/AAC.pmid: 1094944
Lincomycin does not affect initiation factor-dependent formation of 70 S initiation complexes formed with fmet-tRNA F , the initiation triplet A-U-G, and 70 S ribosomes, whereas its 7-chloro-derivative clindamycin substantially stimulates this process. Conversely, lincomycin stimulates nonenzymatic formation of the 70 S complex, but clindamycin does not. Both antibiotics stimulate the assembly of non-enzymatically formed 70 S initiation complexes with R 17 phage ribonucleic acid and exert little effect on those formed in the presence of initiation factors. The formation of 30 S initiation complexes is stimulated or remains unaffected by lincomycin or clindamycin except when initiation occurs in the presence of very low Mg 2+ concentrations. In this case, both antibiotics inhibit the assembly of the 30 S complexes regardless of the messenger present. Antimicrob Agents Chemother. 1975 January; 7(1): 32-37 Copyright © 1975 American Society for Microbiology . All Rights Reserved.
Biological Activity of Staphylococcin 462: Bacteriocin from Staphylococcus aureusHale, E. M.; Hinsdili, R. D.
doi: 10.1128/AAC.pmid: 1137360
Staphylococcin 462 is a proteinaceous inhibitor produced by Staphylococcus aureus strain 462. In broth cultures, susceptible S. aureus strain 140 and 19 respond to treatment with the bacteriocin by stopping growth and cell division. Examination of macromolecular synthesis by measuring the incorporation of radioactive precursors revealed that S. aureus 140 stops synthesizing protein immediately. After exposure to staphylococcin 462, the synthesis of deoxyribonucleic acid and ribonucleic acid is quickly inhibited also, but not as completely. Treatment of S. aureus 140 with the inhibitor causes a rapid drop in cellular adenosine 5'-triphosphate level to about 60% of control levels. Of the 70 strains of gram-positive bacteria tested for susceptibility to staphylococcin 462, 24 (34%), distributed among 7 genera, were susceptible. FOOTNOTES